10.20
2.20 (27.5%)
2.20 (27.5%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ocugen Inc | OCGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 2.20 | 27.5% | 10.20 | 19:59:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.05 | 7.62 | 11.95 | 10.95 | 8.00 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 10.20 | 10.23 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 308,219 | 95,877,407 | $ 9.18 | $ 880,401,864 | 86,724,407 | 0.17 - 18.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:59 | formt | 250 | $ 10.20 | USD |
Ocugen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.65B | 162.03M | 156.81M | $ - | $ - | -8.42 | 0.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Ocugen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.45 | 11.95 | 6.00 | 8.88 | 20,901,154 | -0.25 | -2.39% |
| 1 Month | 1.84 | 18.77 | 1.72 | 9.60 | 114,153,518 | 8.36 | 454.35% |
| 3 Months | 0.3015 | 18.77 | 0.285 | 5.28 | 86,209,137 | 9.90 | 3,283.08% |
| 6 Months | 0.4266 | 18.77 | 0.2501 | 4.73 | 43,219,491 | 9.77 | 2,291.0% |
| 1 Year | 0.4611 | 18.77 | 0.17 | 3.44 | 31,033,262 | 9.74 | 2,112.1% |
| 3 Years | 3.24 | 18.77 | 0.17 | 3.25 | 23,710,949 | 6.96 | 214.81% |
| 5 Years | 3.24 | 18.77 | 0.17 | 3.25 | 23,710,949 | 6.96 | 214.81% |
Ocugen Description
| Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD). |
